Filip Zavadil Kokáš
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Filip Zavadil Kokáš has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Martin Hudeček
Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 779 00 Olomouc, Czech Republic
2 shared publications - Ondřej Plíhal
Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc
2 shared publications - Alejandro Valverde
Antwerp Engineering, Photoelectrochemistry and Sensing (A-PECS), University of Antwerp, Antwerp, 2020, Belgium; NANOlight Centre of Excellence, University of Antwerp, Antwerp, 2020, Belgium
1 shared publication - Anna KuchařOvá
Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 779 00 Olomouc, Czech Republic
1 shared publication - Daniel Nedvěd
Laboratory of Hormonal Regulations in Plants, Institute of Experimental Botany of the Czech Academy of Sciences, Rozvojová 263, 165 00 Prague, Czech Republic
1 shared publication - David Zalabák
Palacký University in Olomouc, Faculty of Science
1 shared publication
Latest Publications
- Open Access
A tonoplast cytokinin riboside transporter gates intracellular hormone availability at the root–microbe interface
Cytokinin ribosides are major mobile and precursor forms of cytokinins, plant hormones whose transport and subcellular distribution shape developmental and stress responses. Here, we identify Arabidopsis thaliana EQUILIBRATIVE NUCLEOSIDE TRANSPORTER1 (ENT1) as a tonoplast-localized cytokinin riboside transporter. Tissue-specific subcellular analysis under native regulatory elements localized ENT1 predominantly to the tonoplast of root epidermal and lateral root cap cells, where it gates intracellular cytokinin riboside availability. Accordingly, ENT1 overexpression enhanced cytokinin riboside sensitivity and signalling, whereas loss of ENT1 altered adenosine metabolism and disrupted cytokinin homeostasis, leading to the accumulation of multiple zeatin-type cytokinins. ENT1-dependent cytokinin riboside compartmentalization was required for beneficial microbe-induced protection, as ent1 mutants failed to acquire protection against the fungal pathogen Botrytis cinerea and the bacterial pathogen Pseudomonas syringae pv. tomato DC3000. These findings reveal a vacuolar gatekeeping mechanism that controls intracellular cytokinin riboside availability and links hormone compartmentalization to beneficial microbe-dependent plant defence.
Open AccessA tonoplast cytokinin riboside transporter gates intracellular hormone availability at the root–microbe interface
Cytokinin ribosides are major mobile and precursor forms of cytokinins, plant hormones whose transport and subcellular distribution shape developmental and stress responses. Here, we identify Arabidopsis thaliana EQUILIBRATIVE NUCLEOSIDE TRANSPORTER1 (ENT1) as a tonoplast-localized cytokinin riboside transporter. Tissue-specific subcellular analysis under native regulatory elements localized ENT1 predominantly to the tonoplast of root epidermal and lateral root cap cells, where it gates intracellular cytokinin riboside availability. Accordingly, ENT1 overexpression enhanced cytokinin riboside sensitivity and signalling, whereas loss of ENT1 altered adenosine metabolism and disrupted cytokinin homeostasis, leading to the accumulation of multiple zeatin-type cytokinins. ENT1-dependent cytokinin riboside compartmentalization was required for beneficial microbe-induced protection, as ent1 mutants failed to acquire protection against the fungal pathogen Botrytis cinerea and the bacterial pathogen Pseudomonas syringae pv. tomato DC3000. These findings reveal a vacuolar gatekeeping mechanism that controls intracellular cytokinin riboside availability and links hormone compartmentalization to beneficial microbe-dependent plant defence.
- Open Access
- 22 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Hypoxia, metastatic origin and HPV16 E6/E7 expression differentially shape the radiation response in head and neck squamous cell carcinoma cell lines
Hypoxia, a common feature of head and neck squamous cell carcinoma (HNSCC), significantly compromises radiotherapy efficacy by modulating DNA repair, cell‑cycle progression, and inflammatory signaling pathways. In addition, intrinsic tumor heterogeneity—including tumor origin and human papillomavirus (HPV) oncogene expression—further shapes therapeutic response. Despite these recognized factors, the integrated impact of oxygen tension, tumor origin, and viral oncogene expression on radiation response remains poorly defined. We examined the effects of hypoxia (1% O 2 ) and gamma-irradiation (6 Gy) on proliferation, cell-cycle progression, apoptosis, transcriptomic profiles, and cytokine secretion in three HNSCC cell lines: FaDu (primary origin), Detroit-562 (metastatic origin), and 2A3, an isogenic FaDu derivative stably expressing HPV-16 E6/E7 oncogenes. Hypoxia prolonged cell doubling time across all lines, independent of origin or E6/E7 expression, while irradiation induced features of an intermediate epithelial–mesenchymal transition phenotype. Compared with FaDu, 2A3 cells exhibited distinct transcriptional responses, reduced cytokine secretion (IL-8, Serpin E1), and altered cell-cycle regulation following irradiation. Detroit-562 cells secreted markedly higher cytokine levels and showed no increase in cleaved caspase-3 under hypoxia after irradiation. Our findings demonstrate that oxygen tension and biological factors—including metastatic origin and E6/E7 expression—modulate radiation response in HNSCC cell lines. These results highlight the need for biomarker-driven strategies that consider both hypoxic tumor microenvironment and key biological factors such as metastatic origin and HPV‑related E6/E7 oncogene expression.
- 22 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessHypoxia, metastatic origin and HPV16 E6/E7 expression differentially shape the radiation response in head and neck squamous cell carcinoma cell lines
Hypoxia, a common feature of head and neck squamous cell carcinoma (HNSCC), significantly compromises radiotherapy efficacy by modulating DNA repair, cell‑cycle progression, and inflammatory signaling pathways. In addition, intrinsic tumor heterogeneity—including tumor origin and human papillomavirus (HPV) oncogene expression—further shapes therapeutic response. Despite these recognized factors, the integrated impact of oxygen tension, tumor origin, and viral oncogene expression on radiation response remains poorly defined. We examined the effects of hypoxia (1% O 2 ) and gamma-irradiation (6 Gy) on proliferation, cell-cycle progression, apoptosis, transcriptomic profiles, and cytokine secretion in three HNSCC cell lines: FaDu (primary origin), Detroit-562 (metastatic origin), and 2A3, an isogenic FaDu derivative stably expressing HPV-16 E6/E7 oncogenes. Hypoxia prolonged cell doubling time across all lines, independent of origin or E6/E7 expression, while irradiation induced features of an intermediate epithelial–mesenchymal transition phenotype. Compared with FaDu, 2A3 cells exhibited distinct transcriptional responses, reduced cytokine secretion (IL-8, Serpin E1), and altered cell-cycle regulation following irradiation. Detroit-562 cells secreted markedly higher cytokine levels and showed no increase in cleaved caspase-3 under hypoxia after irradiation. Our findings demonstrate that oxygen tension and biological factors—including metastatic origin and E6/E7 expression—modulate radiation response in HNSCC cell lines. These results highlight the need for biomarker-driven strategies that consider both hypoxic tumor microenvironment and key biological factors such as metastatic origin and HPV‑related E6/E7 oncogene expression.
- Open Access
- 24 April 2026
- Published by Wiley in New Phytologist
- Vol. 250 (6) , 3846-3866
Cytokinin downregulates Photosystem II photochemistry during prolonged darkness in a phytochrome B‐dependent manner
Summary: Cytokinins (CKs) delay dark‐induced senescence, but how they tune photosynthetic function in darkness remains unclear. We investigated the effects of classical aromatic CK benzylaminopurine and CK‐derived compound 1‐(2‐methoxyethyl)‐3‐(1,2,3‐thiadiazol‐5‐yl)urea on detached Arabidopsis leaves at different time points during dark incubation. Notably, while both compounds mitigated the progression of senescence, they unexpectedly downregulated Photosystem II (PSII) photochemistry during the early stages of dark incubation. Despite this downregulation, CK‐treated leaves preserved functional photochemistry and substantially delayed Chl degradation at later time points. Transcriptomic analysis at the early stage of darkening revealed that a significant portion of CK‐responsive genes is associated with photosynthesis, PSII function, and light sensing, including red‐light signaling pathways. Differential proteomics further supported a CK‐induced shift to a metabolically suppressed state. The early PSII downregulation required phytochrome B, indicating a CK–phyB module that places darkened leaves into a reversible ‘standby’ mode, limiting energy demand and enabling rapid, safer recovery of photosynthesis upon re‐illumination. At the same time, it may also protect the photosynthetic apparatus against photo‐oxidative damage during the transition from dark‐ to light‐adapted states.
- 24 April 2026
- Published by Wiley in New Phytologist
- Vol. 250 (6) , 3846-3866
Open AccessCytokinin downregulates Photosystem II photochemistry during prolonged darkness in a phytochrome B‐dependent manner
Summary: Cytokinins (CKs) delay dark‐induced senescence, but how they tune photosynthetic function in darkness remains unclear. We investigated the effects of classical aromatic CK benzylaminopurine and CK‐derived compound 1‐(2‐methoxyethyl)‐3‐(1,2,3‐thiadiazol‐5‐yl)urea on detached Arabidopsis leaves at different time points during dark incubation. Notably, while both compounds mitigated the progression of senescence, they unexpectedly downregulated Photosystem II (PSII) photochemistry during the early stages of dark incubation. Despite this downregulation, CK‐treated leaves preserved functional photochemistry and substantially delayed Chl degradation at later time points. Transcriptomic analysis at the early stage of darkening revealed that a significant portion of CK‐responsive genes is associated with photosynthesis, PSII function, and light sensing, including red‐light signaling pathways. Differential proteomics further supported a CK‐induced shift to a metabolically suppressed state. The early PSII downregulation required phytochrome B, indicating a CK–phyB module that places darkened leaves into a reversible ‘standby’ mode, limiting energy demand and enabling rapid, safer recovery of photosynthesis upon re‐illumination. At the same time, it may also protect the photosynthetic apparatus against photo‐oxidative damage during the transition from dark‐ to light‐adapted states.
- Open Access
Clamp the LAMP: a photoelectrochemical platform for KRAS mutation detection via wild-type blocking
KRAS mutations are among the most prevalent oncogenic alterations in colorectal, lung, and pancreatic cancer, yet their detection remains analytically challenging in the presence of an overwhelming wild-type (WT) background. Here, we report a photoelectrochemical (PEC) genotyping platform that integrates clamp-inhibited loop-mediated isothermal amplification (C-LAMP) with enzyme-free singlet oxygen ( 1 O 2 )-driven PEC transduction for mutation-selective KRAS detection. Locked nucleic acid (LNA) clamp probes selectively suppress WT amplification during isothermal amplification, enriching mutant alleles and enabling single-nucleotide variant (SNV) discrimination with high selectivity. Amplified products are magnetically captured and transduced into photocurrent via visible-light-induced 1 O 2 redox cycling, eliminating enzymatic reporters and reducing background interference. The C-LAMP/PEC platform achieves a limit of detection of 35 copies µL -1 (58 aM) and a minimum detectable variant allele frequency (VAF) of 4.8% in heterogeneous mutant/WT genomic DNA mixtures. Analytical performance was validated in cancer cell lines and in patient-derived fresh frozen tissues, showing complete concordance with Nanopore sequencing and droplet digital PCR (ddPCR) within the evaluated cohort (n = 16). This work introduces a robust and modular PEC biosensing strategy that combines molecular WT suppession with enzyme-free photoelectrochemistry, offering an economically competitive and instrumentation-simplified approach for clinically relevant KRAS mutation analysis toward decentralized testing.
Open AccessClamp the LAMP: a photoelectrochemical platform for KRAS mutation detection via wild-type blocking
KRAS mutations are among the most prevalent oncogenic alterations in colorectal, lung, and pancreatic cancer, yet their detection remains analytically challenging in the presence of an overwhelming wild-type (WT) background. Here, we report a photoelectrochemical (PEC) genotyping platform that integrates clamp-inhibited loop-mediated isothermal amplification (C-LAMP) with enzyme-free singlet oxygen ( 1 O 2 )-driven PEC transduction for mutation-selective KRAS detection. Locked nucleic acid (LNA) clamp probes selectively suppress WT amplification during isothermal amplification, enriching mutant alleles and enabling single-nucleotide variant (SNV) discrimination with high selectivity. Amplified products are magnetically captured and transduced into photocurrent via visible-light-induced 1 O 2 redox cycling, eliminating enzymatic reporters and reducing background interference. The C-LAMP/PEC platform achieves a limit of detection of 35 copies µL -1 (58 aM) and a minimum detectable variant allele frequency (VAF) of 4.8% in heterogeneous mutant/WT genomic DNA mixtures. Analytical performance was validated in cancer cell lines and in patient-derived fresh frozen tissues, showing complete concordance with Nanopore sequencing and droplet digital PCR (ddPCR) within the evaluated cohort (n = 16). This work introduces a robust and modular PEC biosensing strategy that combines molecular WT suppession with enzyme-free photoelectrochemistry, offering an economically competitive and instrumentation-simplified approach for clinically relevant KRAS mutation analysis toward decentralized testing.